AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...
Lipids act as extracellular and intracellular messengers to control cell fate in normal physiology and disease. When deregulated, lipid signalling contributes to inflammation and cancer, metabolic, ...